Target intelligence / Profile preview

Transducin-like enhancer protein 4 (TLE4)

Target
TLE4
Molecular classification
Transcriptional corepressor, Transcription regulator
01

Overview

Transducin-like enhancer protein 4 (TLE4) is a member of the TLE/groucho family of transcriptional corepressors that do not directly bind DNA but regulate gene expression via interaction with transcription factors, including Hes1 and PAX5. TLE4 possesses an N-terminal Q domain for tetramerization and a C-terminal WD repeat domain for protein interaction; it acts as a critical regulator of hematopoiesis, B-cell differentiation, and inflammatory responses. Specifically, TLE4 represses the expression of pro-inflammatory cytokines such as IL-6 and IL-12 in macrophages, modulating immune homeostasis. TLE4 also contributes to the negative regulation of the canonical Wnt signaling pathway and is important for normal skeletal and bone marrow development. In disease, TLE4 deletion or dysfunction is implicated particularly in acute myeloid leukemia as a synergistic factor in oncogenesis and in immune dysregulation.

Other names
GRG4KIAA1261BCE-1BCE1E(spl)ESG4Grg-4enhancer of split groucho 4B lymphocyte gene 1Groucho-related protein 4transducin-like enhancer of split 4E(sp1) homolog (Drosophila)homolog of Drosophila E(sp1)TLE family member 4transcriptional corepressor
02

Biological functions

Negative regulation of transcription by RNA polymerase IINegative regulation of canonical Wnt signaling pathwayRegulation of hematopoiesisInhibition of inflammatory cytokine expression (e.g., IL-6, IL-12)Suppression of acute inflammation
03

Disease associations

Cancer (notably acute myeloid leukemia (AML))LeukemiaImmune disordersBone development abnormalitiesAbnormal hematopoiesis
04

Safety considerations

Potential effects on immune regulation and inflammation (loss of TLE4 enhances pro-inflammatory cytokine expression; knockout associated with greater susceptibility to septic shock and hematopoietic abnormalities)Growth defects and skeletal abnormalities seen in knockout mice

Beyond the preview

Go deeper on Transducin-like enhancer protein 4 (TLE4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transducin-like enhancer protein 4 (TLE4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call